Interrupted time series analysis for the weekly number of dependent group inpatients with ischemic stroke between April 1 2018 and June 27 2020. by Hiroyuki Nagano (4013804)

Subjects:

Result of the interrupted time series analysis for the weekly number of independent group inpatients with ischemic stroke between April 1 2018 and June 27 2020. by Hiroyuki Nagano (4013804)

Subjects:

Flow of case selection. by Hiroyuki Nagano (4013804)

Subjects:

Result of the interrupted time series analysis for the weekly number of inpatients with ischemic stroke between April 1 2018 and June 27 2020. by Hiroyuki Nagano (4013804)

Subjects:

The result of interrupted time series analysis for weekly proportions of inpatient cases receiving intravenous thrombolysis between April 1 2018 and June 27 2020. by Hiroyuki Nagano (4013804)

Subjects:

The total number, characteristics, and time-sensitive treatment approaches of inpatient cases with ischemic stroke before and after the declaration of state of emergency. by Hiroyuki Nagano (4013804)

Subjects:

The result of the interrupted time series analysis for weekly proportions of inpatient cases receiving endovascular intervention between April 1 2018 and June 27 2020. by Hiroyuki Nagano (4013804)

Subjects:

MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

The wound appearance of different groups during the period of study (a) and the percentage of wound reduction in treated groups on different days (b). by Omid Mehrpour (9385929)

Subjects:

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

Subjects:

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Subjects:

Data_Sheet_1_Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.docx by Livia De Picker (8319105)

“…</p><p>Conclusion: The acute psychotic state is marked by state-specific increases of immune markers and decreases in peripheral IDO pathway markers. …”

NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). by Xueqin lu (22250795)

Subjects:

Significant achievement in reduction of maternal and neonatal deaths. by Ruoyan Gai Tobe (102986)

Lab parameters–Significant reduction in means. by Harleen Kaur (288288)

“…Adjuvant homoeopathic medicines were given in the treatment group and SOC was given to both groups. The duration of oxygen support was compared as the primary outcome. …”

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects: